The Research Question Does self monitoring of blood glucose (SMBG) in patients with non-insulin treated type 2 diabetes improve glycemia or quality of.

Slides:

Advertisements

Similar presentations

Biomedical Research Models, Inc., Worcester, MA

Advertisements

Connected Health: Care Anywhere Douglas J. McClure Corporate Manager Center for Connected Health Partners HealthCare 3/23/2009.

Self-Management Education Chapter 7 Helen Jones, Lori D Berard, Gail MacNeill, Dana Whitham, Catherine Yu Canadian Diabetes Association 2013 Clinical Practice.

National Diabetes Statistics Report Fun Facts on Diabetes 29.1 million people or 9.3% of the US population have diabetes. Diagnose : 21.0 million people.

Canadian Diabetes Assocaition Clinical Practice Guidelines Pharmacotherapy in Type 1 Diabetes Chapter 12 Angela McGibbon, Cindy Richardson, Cheri Hernandez,

Looking after your diabetes Dr Gill Hood North Thames Clinical Research Network

Diabetes Programme Progress Report Dr Charles Gostling, Joint Diabetes Clinical Director October 2013.

LONG TERM BENEFITS OF ORAL AGENTS

Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.

INSULIN THERAPY IN TYPE 1 DIABETES

A Day in the Life of a Type 2 Diabetic

Presented by Dr. Soe Sandi Tint

Diabetes Connected Health: A Pilot Study of a Patient- and Provider-Shared Glucose Monitoring Web Application Journal of Diabetes Science and Technology.

An Innovative Approach to Managing Diabetes in a Large Public Health System Donna J. Calvin, PhD, FNP-BC, CNN Post Doctoral Research Associate University.

Information Skills Training: Information Literacy and You Lauren Maggio, MS (LIS), MA Medical Education Librarian Keith Posley, MD, MS Clinical Assistant.

United Regional Diabetes Education Laura Gutierrez, R.N. CDE Diabetes Education Manager.

Dr Stanley Ngare.  Pharmacology of Types of insulin available  Various routes of delivery & factors that affect absorption  Patient and provider barriers.

BY KURT GUTORMSON Can Gene Therapy Cure Diabetes?.

Agenda Introduction to established biomarker, HbA1c Objectives

Health in Your Community Chapter 1 Section 3. Public Health  Practice of protecting and improving the health of people in a community.

Overcoming Clinical Inertia: A Randomized Clinical Trial of a Telehealth Remote Monitoring Intervention using Paired Glucose Testing in Adults with Type.

Date of download: 6/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of Health Maintenance Organization Coverage.

Effect of a Community-Based Self-help Management Program for Patients with Diabetes Mellitus Effect of a Community-Based Self-help Management Program for.

Acknowledgments Lifescan Inverness Introduction  Diabetes Mellitus is the 5 th most common cause of death in the world  Life expectancy reduced on average.

Introduction Subcutaneous insulin absorption is not reproducible and insulin entry directly into the circulation is not linked to glucose sensing Basal.

Glycemia Treatment Strategies Used In ACCORD

Baseline characteristics

Health Numeracy & Literacy:

Copyright © 2015 by the American Osteopathic Association.

Explanations of SMBG Non-Adherence

(at least quartely clinical and “basic” laboratory examinations)

Copyright © 2017 American Academy of Pediatrics.

Copyright © 2006 American Medical Association. All rights reserved.

Neal B, et al. Diabetes Care 2015;38:403–411

Copyright © 2004 American Medical Association. All rights reserved.

Canagliflozin: Real World Experience

FreeStyle Libre Glucose Monitoring System

Type 1 Diabetes: Meters, Pumps, and Transitions to Adulthood

Diabetes Health Status Report

Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.

What is the Value of Home Glucose Monitoring?

Management of Type II Diabetes

Hemoglobin A1c Targets for Glycemic Controls

Sodium-glucose co-transporter 2 (SGLT2) inhibitors work by blocking the reabsorption of filtered glucose in the kidneys. This leads to glucosuria and improved.

Clinical Application of Incretin-Based Therapy: Therapeutic Potential, Patient Selection and Clinical Use David M. Kendall, MD, Robert M. Cuddihy, MD,

Integrated Diabetes Care: How Can We Make the Best Use of New Technology?

George Dailey, MD Mayo Clinic Proceedings

Gerry H. Tan, M.D., Roger L. Nelson, M.D. Mayo Clinic Proceedings

The Cardiologist's Mindset in the Management of Diabetes and Coronary Artery Disease: Today and Tomorrow.

Fig. 1. Glycemic variability in three hypothetical patients who have the same mean blood glucose concentration. Patient B has relatively small variations.

T2DM Management.

Better Diabetes Control With Novel Basal Insulins

Modern Advances in Glucose Monitoring

Dual SGLT1/SGLT2 Inhibition in T1D

Key Insulin Side Effects*

Hypoglycemia: The Most Common Barrier to Effective Diabetes Management

Self-Management Education and Support

Glycemic Management in Adults with Type 1 Diabetes

Reduction in self-monitoring of blood glucose in type 2 diabetes: an observational controlled study in east London by John Robson, Hannah Smithers, Tahseen.

Mean daily glucose concentration and frequency of hypoglycemia in long-term care residents with type 2 diabetes. Mean daily glucose concentration and frequency.

Campbell FM, et al. Pediatr Diabetes. 2018;19(7):1294–1301

Measuring Palliative Care Outcomes

Percentage of patients who had their pre-evening capillary blood glucose monitored at least once during their steroid therapy. Percentage of patients who.

Effect of anandamide on blood glucose clearance and insulin sensitivity. Effect of anandamide on blood glucose clearance and insulin sensitivity. A: Intraperitoneal.

Sulphonylureas and Glitazones In spite of the big number of anti-diabetic factors obtainable.

Representative study BG profiles from the forearm and the fingertip of six patients with diabetes. Representative study BG profiles from the forearm and.

Metabolic parameters in the three groups of patients during l-arginine infusion. Metabolic parameters in the three groups of patients during l-arginine.

Mean changes (standard error) from baseline in A1C (A and B) and body weight (C and D) for patients with type 1 (A and C) or type 2 (B and D) diabetes.

The Power of As-Treated Analyses

Presentation transcript:

The Research Question Does self monitoring of blood glucose (SMBG) in patients with non-insulin treated type 2 diabetes improve glycemia or quality of life?

What the Researchers Did Pragmatic RCT of 3 SMBG testing approaches over 1 year in 450 patients with non-insulin treated type 2 diabetes Group 1: No SMBG testing Group 2: Once daily SMBG testing with standard feedback Glucose values reported on monitor Group 3: Once daily SMBG testing with enhanced feedback Glucose values reported on monitor plus a tailored feedback message delivered to the patient through the monitor

What the Researchers Found Over the course of 1 year, there were no clinically or statistically significant differences in glycemic control or quality of life between patients with non insulin treated diabetes who perform SMBG compared to those who do not perform SMBG The addition of tailored feedback provided through messaging via a glucometer did not provide any advantage in glycemic control

What This Means for Clinical Practice Glucose monitoring in patients with non-insulin treated type 2 diabetes should not be routine. Enhanced glucose monitoring, at least in the pragmatic real world setting offered no additional health benefits